Deerfield Management Company, L.P. (Series C) Rx Sight, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$50.42 - $64.29 $38,167 - $48,667	757 Added 9.25%	8,942 $538,000
Q1 2024 May 15, 2024	BUY	$35.51 - $57.92 $290,649 - $474,075	8,185 New	8,185 $422,000
Q4 2021 Feb 14, 2022	SELL	$9.52 - $13.81 $8.57 Million - $12.4 Million	-900,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.85 - $17.32 $10.7 Million - $15.6 Million	900,000 New	900,000 $11.4 Million

Others Institutions Holding RXST

# of Institutions

224

Shares Held

32.3M

Call Options Held

394K

Put Options Held

32K

Ra Capital Management, L.P. Boston, MA

3.92M
Shares

$132 Million
2.7% of portfolio
Black Rock Inc. New York, NY

2.4M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.29M
Shares

$77 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

1.75M
Shares

$58.8 Million
0.01% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

1.17M
Shares

$39.4 Million
0.09% of portfolio

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $930M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account